• Home
  • Search Results
  • A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.

Cell (2020-03-07)
Ina Nemet, Prasenjit Prasad Saha, Nilaksh Gupta, Weifei Zhu, Kymberleigh A Romano, Sarah M Skye, Tomas Cajka, Maradumane L Mohan, Lin Li, Yuping Wu, Masanori Funabashi, Amanda E Ramer-Tait, Sathyamangla Venkata Naga Prasad, Oliver Fiehn, Federico E Rey, W H Wilson Tang, Michael A Fischbach, Joseph A DiDonato, Stanley L Hazen
ABSTRACT

Using untargeted metabolomics (n = 1,162 subjects), the plasma metabolite (m/z = 265.1188) phenylacetylglutamine (PAGln) was discovered and then shown in an independent cohort (n = 4,000 subjects) to be associated with cardiovascular disease (CVD) and incident major adverse cardiovascular events (myocardial infarction, stroke, or death). A gut microbiota-derived metabolite, PAGln, was shown to enhance platelet activation-related phenotypes and thrombosis potential in whole blood, isolated platelets, and animal models of arterial injury. Functional and genetic engineering studies with human commensals, coupled with microbial colonization of germ-free mice, showed the microbial porA gene facilitates dietary phenylalanine conversion into phenylacetic acid, with subsequent host generation of PAGln and phenylacetylglycine (PAGly) fostering platelet responsiveness and thrombosis potential. Both gain- and loss-of-function studies employing genetic and pharmacological tools reveal PAGln mediates cellular events through G-protein coupled receptors, including α2A, α2B, and β2-adrenergic receptors. PAGln thus represents a new CVD-promoting gut microbiota-dependent metabolite that signals via adrenergic receptors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethylenediaminetetraacetic acid disodium salt dihydrate, suitable for electrophoresis, for molecular biology, 99.0-101.0% (titration)
Sigma-Aldrich
Chloramphenicol, ≥98% (HPLC)
Sigma-Aldrich
3-Isobutyl-1-methylxanthine, ≥99% (HPLC), powder
Sigma-Aldrich
Sodium thioglycolate, ≥96.5% (iodometric)
Sigma-Aldrich
Rhodamine 6G, Dye content 99 %
Sigma-Aldrich
(±)-Epinephrine hydrochloride
Sigma-Aldrich
(±)-Norepinephrine (+)-bitartrate salt
Sigma-Aldrich
Rolipram, solid, ≥98% (HPLC)
Sigma-Aldrich
Leupeptin, synthetic, ≥85% (HPLC)
Sigma-Aldrich
Propyl chloroformate, 98%
Sigma-Aldrich
Phenylacetyl-L-glutamine, ≥95%
Supelco
N-(2-Phenylacetyl)glycine, analytical standard
Sigma-Aldrich
PhenylAc-Gln-OH, AldrichCPR
Sigma-Aldrich
MISSION® esiRNA, targeting human ADRA2B
Sigma-Aldrich
MISSION® esiRNA, targeting human ADRB2
BRAND® 96-well microplate, U-bottom, round bottom, non-sterile